These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6275456)

  • 1. Evidence for a dual action of converting enzyme inhibitor on blood pressure in normal man.
    Goldstone R; Martin K; Zipser R; Horton R
    Prostaglandins; 1981 Oct; 22(4):587-98. PubMed ID: 6275456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renin and aldosterone secretion under converting enzyme inhibition].
    Nakamura K
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the beta-adrenergic system and prostaglandins stimulate renin release through different mechanisms.
    Hsueh WA; Goldstone R; Carlson EJ; Horton R
    J Clin Endocrinol Metab; 1985 Sep; 61(3):399-403. PubMed ID: 2991316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal changes in active and inactive renin after converting enzyme inhibition in normal man.
    Goldstone R; Horton R; Carlson EJ; Hsueh WA
    J Clin Endocrinol Metab; 1983 Feb; 56(2):264-8. PubMed ID: 6296183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose captopril administration in DOCA/salt rats: reduction of hypotensive effect by indomethacin.
    Miyamori I; Brown MJ; Dollery CT
    Clin Exp Hypertens (1978); 1980; 2(6):935-45. PubMed ID: 7004806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin--angiotensin--aldosterone system in the maintenance of blood pressure, aldosterone secretion and sodium balance in normotensive subjects.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC; Morton JJ
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():95s-99s. PubMed ID: 7004744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects.
    Anderson PW; Malarkey WB; Salk J; Kletsky OA; Hsueh WA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):518-22. PubMed ID: 2503532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converting enzyme inhibition during chronic angiotensin II infusion in rats. Evidence against a nonangiotensin mechanism.
    Textor SC; Brunner HR; Gavras H
    Hypertension; 1981; 3(2):269-76. PubMed ID: 6260647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man.
    Speckart P; Zia P; Zipser R; Horton R
    J Clin Endocrinol Metab; 1977 May; 44(5):832-7. PubMed ID: 870512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.
    Swartz SL; Williams GH; Hollenberg NK; Levine L; Dluhy RG; Moore TJ
    J Clin Invest; 1980 Jun; 65(6):1257-64. PubMed ID: 6997332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep.
    Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin and angiotensin converting enzyme inhibition: effect on blood pressure, renin activity and renal function in hemorrhaged conscious rabbits.
    Golub MS; Berger ME; Sambhi MP; Eggena P
    Clin Exp Hypertens (1978); 1981; 3(3):477-95. PubMed ID: 6265167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects.
    Sancho J; Re R; Burton J; Barger AC; Haber E
    Circulation; 1976 Mar; 53(3):400-5. PubMed ID: 174834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged converting enzyme inhibition in non-modulating hypertension.
    Dluhy RG; Smith K; Taylor T; Hollenberg NK; Williams GH
    Hypertension; 1989 Apr; 13(4):371-7. PubMed ID: 2538393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of captopril-induced renin release by angiotensin II.
    Mersey JH; Ceballos L; Swartz S
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):575-9. PubMed ID: 2447408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
    McCaa RE
    Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of endogenous prostaglandin system in the antihypertensive effect of captopril, SQ 14225, in low renin hypertension.
    Abe K; Itoh T; Imai Y; Sato M; Haruyama T; Sakurai Y; Goto T; Otsuka Y; Yoshinaga K
    Jpn Circ J; 1980 May; 44(5):422-5. PubMed ID: 6993721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.